Vimarsana
Biggest News Aggregation in the World

Page 8 - Cellular Immune News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cellular Immune. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cellular Immune Today - Breaking & Trending Today

Maze Therapeutics initiates dosing in Phase I Pompe disease therapy trial - Vimarsana News

Maze Therapeutics initiates dosing in Phase I Pompe disease therapy trial

Maze has commenced participant dosing in its Phase I clinical trial of oral glycogen synthase (GYS1) inhibitor, MZE001, to treat Pompe diseas

IACT Health, LMC Manna and True North become Centricity Research - Vimarsana News

IACT Health, LMC Manna and True North become Centricity Research

Clinical research companies IACT Health, LMC Manna Research and True North Clinical Research have joined forces to form Centricity Research.

Sensorion's SENS-401 fails to meet primary goal in Phase II SSNHL trial - Vimarsana News

Sensorion's SENS-401 fails to meet primary goal in Phase II SSNHL trial

Sensorion announced that Phase II trial of SENS-401 (Arazasetron) to treat sudden sensorineural hearing loss failed to meet primary goal.

I-Mab doses first subject in solid tumour therapy trial in China - Vimarsana News

I-Mab doses first subject in solid tumour therapy trial in China

I-Mab has dosed the first subject in Phase II trial of efineptakin alfa plus pembrolizumab in advanced solid tumour patients in China.